课题基金 / 基金详情

Studies on the significance of bioactive gangliosides in cellular growth and differntiation.

Studies on the significance of bioactive gangliosides in cellular growth and differntiation.
生物活性神经节苷脂在细胞生长和分化中的意义的研究。
批准号:
60440102
负责人:
NAGAI Yoshitaka
金额:
$15.49万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (A)
财政年份:
1985
资助国家:
日本
项目状态:
已结题
起止时间:
1985 至 1988

项目摘要

项目成果

NAGAI Yoshitaka的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Carbohydrate recognition at cell surface is known to importantly be involved in cell to cell interactions, cell growth and differentiation.Most of such modulatory potentials have so far been reported on a family of sialylated glycosphingolipids, gangliosides, using cultured cell system added with these glycolipids exogenously. We previously reported that a disialoganglioside GD3 strongly promotes ions and water transport in cultured kidney epithelial cells (MDCK). Newly and specific appearance of GD3 was observed in rat embryonic fibroblastic cells, 3Y1, which were transfected and transformed with various oncogenes of DNA-virus origin (adenovirus E1A, SV40-T and myc). The monoclonal antibody to GD3 reversibly inhibits cell growth of these cells. The remarkable elevation of GD3 was reported on neuron and glial cells in their proliferative states. More recently we have found that a tetrasialoganglioside G 1b specifically can promote differentiation of the human neuroblastoma cells, leading to the promotion of neuritogenesis and also that G 1b specifically stimulates the phosphorylation of several cell surface proteins of the same cells, when the G 1b and ATP are added to the cells. The results indicate that this cell surface protein phosphorylation might be carried out by unique cell surface membrane protein kinase(s) (ecto-Gg kinase) which is specifically activated by a particular ganglioside. Inhibition of this phosphorylation resulted in the inhibition of G 1b-dependent promotion of neuritogenesis, strongly suggesting the interrelationship between those two cell events and occurrence of a new biosignal transduction, ecto biosignal transduction system.
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
S.Kosugi: Biochem.Biophys.Res.Commun.143. 848-855 (1987)
S.Kosugi:Biochem.Biophys.Res.Commun.143。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
S.Tsuji: "Bioactive gangliosides. IV. ganglioside GQlb/Ca^<2+> dependent protein kinase activity exists in the plasma membrane fraction of neuroblastoma cell line, GOTO." J. Biochem.97. 969-972 (1985)
S.Tsuji:“生物活性神经节苷脂。IV.神经母细胞瘤细胞系GOTO的质膜部分中存在神经节苷脂GQlb/Ca^2依赖性蛋白激酶活性。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
J.Nakajima: "Bioactive gangliosides: analysis of functional structures of the tetrasialoganglioside GQlb which promotes neurite outgrowth." Biochim. Biophys. Acta. 876. 65-71 (1986)
J.Nakajima:“生物活性神经节苷脂:促进神经突生长的四唾液酸神经节苷脂 GQlb 的功能结构分析。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
H.Nakaishi: "Analysis of cellular expression of gangliosides by gene transfection I: GD3 expression in myc-transfected and transformed 3Y1 correlates anchorage-independent growth activity." Biochem. Biophys. Res. Commun.150. 760-765 (1988)
H.Nakaishi:“通过基因转染对神经节苷脂的细胞表达进行分析 I:myc 转染和转化的 3Y1 中的 GD3 表达与锚定无关的生长活性相关。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
46
    Establishment and pathological analyses of transgenic marmoset models of polyglutamine diseases
    • 批准号:
      26670446
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2014
    • 负责人:
      NAGAI Yoshitaka
    • 依托单位:
    A gain of toxic function hypothesis via accumulated RNA-binding protein and repeat RNA in the pathogenesis of ALS and its validation in vivo
    Therapeutic strategy for the polyglutamine diseases by selective degradation of expanded polyglutamine proteins using polyglutamine-binding pepetides
    • 批准号:
      23390237
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.23万
    • 财政年份:
      2011
    • 负责人:
      NAGAI Yoshitaka
    • 依托单位:
    Development of a drug for the polyglutamine diseases by molecular design of chemical analogues of the aggregation inhibitor peptide QBP1
    • 批准号:
      22659172
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.11万
    • 财政年份:
      2010
    • 负责人:
      NAGAI Yoshitaka
    • 依托单位:
    海外基金